Caltic

Developer of TRPC inhibitors for the treatment of metabolic and pathological cardiac conditions

placeDortmund, North Rhine Westphalia, Germany calendar_todayFounded 2021 language cal-tic.com

Registered entities

Investor mix

1 investor on record; lead investors include KHAN-I.

Investor typeCountShare
Venture capital1100%
Coming soon